| 2024-11-04 | +28.2% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2024-11-04 | +28.2% | legal | SEC EDGAR | IART 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-05 | -22.9% | earnings | Seeking Alpha | Integra LifeSciences plans $390M-$400M Q2 revenue amid compliance initiatives |
| 2025-05-05 | -22.9% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Q1 2025 Earnings Call Transcript |
| 2025-05-05 | -22.9% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-05 | -22.9% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.41 misses by $0.02, revenue of $382.65M beats by $1.48M |
| 2025-05-05 | -22.9% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2025-05-05 | -22.9% | news | Yahoo Finance | Why Integra LifeSciences (IART) Shares Are Getting Obliterated Today - Yahoo Finance |
| 2025-05-05 | -22.9% | news | StockStory | Why Integra LifeSciences (IART) Shares Are Getting Obliterated Today - StockStory |
| 2025-10-30 | -21.4% | earnings | Seeking Alpha | Integra outlines $1.62B–$1.64B 2025 revenue target as supply chain, product relaunches drive strategic transformation |
| 2025-10-30 | -21.4% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Q3 2025 Earnings Call Transcript |
| 2025-10-30 | -21.4% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.54 beats by $0.11, revenue of $402.06M misses by $12.25M |
| 2025-10-30 | -21.4% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2025-10-30 | -21.4% | news | Yahoo Finance | Why Integra LifeSciences (IART) Shares Are Sliding Today - Yahoo Finance |
| 2025-10-30 | -21.4% | earnings | MassDevice | Integra stock dips on lowered guidance after Q3 sales miss - MassDevice |
| 2025-10-30 | -21.4% | earnings | StockStory | Integra LifeSciences (NASDAQ:IART) Misses Q3 Sales Expectations - StockStory |
| 2023-05-23 | -21.0% | news | GlobeNewswire | Kaplan Fox Investigates Integra LifeSciences Holdings Corporation (NASDAQ: IART) - GlobeNewswire |
| 2025-05-02 | -20.1% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation Q1 2025 Earnings Preview |
| 2024-07-29 | -19.9% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2024-07-29 | -19.9% | earnings | InvestorPlace | IART Stock Earnings: Integra Lifesciences Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace |
| 2025-02-24 | +17.9% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation Q4 2024 Earnings Preview |
| 2024-02-28 | -16.9% | legal | SEC EDGAR | IART 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-02-28 | -16.9% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2024-05-06 | -14.3% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2024-02-27 | -12.5% | legal | SEC EDGAR | IART 8-K: 5.02 (SEC Filing) |
| 2022-10-26 | +12.4% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2025-11-21 | +10.5% | news | TradingView | Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - TradingView |
| 2025-08-12 | +9.3% | news | StockStory | Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know - StockStory |
| 2025-07-21 | +8.1% | legal | Seeking Alpha | Integra recalls MicroMyst Applicators for sterilization concerns: FDA |
| 2025-07-21 | +8.1% | news | simplywall.st | Is Integra LifeSciences Holdings (NASDAQ:IART) Using Too Much Debt? - simplywall.st |
| 2023-04-26 | -7.7% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2025-11-24 | +7.6% | news | StockStory | Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know - StockStory |
| 2026-02-27 | -7.5% | earnings | simplywall.st | Integra LifeSciences Holdings (IART) Quarterly Losses Challenge Bullish Margin Recovery Narrative - simplywall.st |
| 2026-02-27 | -7.5% | news | StockStory | Stocks making big moves this week: Flywire, First Advantage, Integra LifeSciences, Huron, and Montrose - StockStory |
| 2025-02-25 | +7.5% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation 2024 Q4 - Results - Earnings Call Presentation |
| 2025-02-25 | +7.5% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Q4 2024 Earnings Call Transcript |
| 2025-02-25 | +7.5% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.97 beats by $0.12, revenue of $442.6M misses by $2.55M |
| 2025-02-25 | +7.5% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2025-07-14 | -6.5% | legal | Quiver Quantitative | Integra LifeSciences to Announce Second Quarter 2025 Financial Results on July 31 - Quiver Quantitative |
| 2025-03-06 | +6.4% | analyst | Seeking Alpha | Integra LifeSciences: Light At The End Of The Tunnel, Or Another Oncoming Train? (Rating Upgrade) |
| 2026-03-02 | -6.4% | earnings | TradingView | Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up - TradingView |
| 2025-05-13 | -6.3% | legal | SEC EDGAR | IART 8-K: 5.02, 5.07, 8.01 (SEC Filing) |
| 2021-11-02 | +6.1% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2026-03-23 | +6.0% | news | StockStory | 3 Stocks Under $10 We Think Twice About - StockStory |
| 2026-03-23 | +6.0% | news | The Globe and Mail | 3 Stocks Under $10 We Think Twice About - The Globe and Mail |
| 2026-01-23 | -5.9% | news | Benzinga | What's Going On With Integra LifeSciences Stock Friday? - Integra Lifesciences (NASDAQ:IART) - Benzinga |
| 2022-07-27 | -5.4% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2026-02-23 | -5.3% | news | TradingView | Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know - TradingView |
| 2026-02-23 | -5.3% | news | FinancialContent | Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know - FinancialContent |
| 2025-11-03 | -4.9% | news | Yahoo Finance | Why Integra LifeSciences (IART) Shares Are Trading Lower Today - Yahoo Finance |
| 2026-04-20 | -4.7% | news | GlobeNewswire | Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026 |
| 2026-04-20 | -4.7% | earnings | Stock Titan | Integra LifeSciences posts Q1 results May 5 before market open - Stock Titan |
| 2023-12-13 | +4.6% | legal | SEC EDGAR | IART 8-K: 5.02 and (SEC Filing) |
| 2023-12-13 | +4.6% | legal | SEC EDGAR | IART 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-11-01 | -4.5% | earnings | Yahoo Finance | Integra LifeSciences (IART): Deep Losses and Discounted Valuation Shape Sentiment Ahead of Earnings - Yahoo Finance |
| 2025-12-18 | -4.4% | news | Seeking Alpha | Integra LifeSciences: Potential Only Takes You So Far Without Execution |
| 2025-12-18 | -4.4% | news | Seeking Alpha | Integra LifeSciences: Potential Only Takes You So Far Without Execution (NASDAQ:IART) - Seeking Alpha |
| 2025-08-01 | -4.3% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call Transcript |
| 2025-10-20 | +4.3% | news | Yahoo Finance | Integra LifeSciences Holdings (IART): Examining Valuation After Recent Share Price Rebound - Yahoo Finance |
| 2025-10-20 | +4.3% | legal | Yahoo Finance | What Recent FDA Clearance Means for Integra LifeSciences Holdings Stock Valuation - Yahoo Finance |
| 2021-10-28 | -4.2% | legal | SEC EDGAR | IART 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-06-21 | +4.1% | news | Seeking Alpha | Integra LifeSciences Still Underperforming As Manufacturing Issues Linger (NASDAQ:IART) - Seeking Alpha |
| 2026-04-21 | -4.0% | news | StockStory | 3 Cash-Burning Stocks That Concern Us |
| 2026-04-21 | -4.0% | news | GlobeNewswire | [Latest] Global Surgical Drill Bits Market Size/Share Worth USD 540 Million by 2035 at a 5.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) |
| 2026-04-21 | -4.0% | earnings | MarketBeat | Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat |
| 2025-09-08 | -4.0% | news | StockStory | Why Integra LifeSciences (IART) Stock Is Down Today - StockStory |
| 2026-01-04 | +3.9% | news | Yahoo Finance | 3 Reasons to Sell IART and 1 Stock to Buy Instead - Yahoo Finance |
| 2025-01-06 | -3.8% | legal | SEC EDGAR | IART 8-K: 8.01 (SEC Filing) |
| 2025-05-06 | -3.7% | earnings | Yahoo Finance | Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance |
| 2025-05-06 | -3.7% | news | PR Newswire | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART - PR Newswire |
| 2025-05-06 | -3.7% | news | GlobeNewswire | Attention Long-Term Shareholders of Integra LifeSciences - GlobeNewswire |
| 2022-10-19 | -3.6% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Integra LifeSciences (IART) - Zacks Investment Research |
| 2026-03-15 | -3.5% | news | AD HOC NEWS | Integra LifeSciences Stock (ISIN: US4579851036) Faces Headwinds Amid Tissue Technology Challenges - AD HOC NEWS |
| 2024-12-17 | -3.2% | legal | SEC EDGAR | IART 8-K: 5.02 and (SEC Filing) |
| 2026-04-15 | -3.0% | earnings | StockStory | Q4 Rundown: Integra LifeSciences (NASDAQ:IART) Vs Other Surgical Equipment & Consumables - Specialty Stocks |
| 2026-04-15 | -3.0% | analyst | The Fly | Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls |
| 2026-04-15 | -3.0% | earnings | MT Newswires | Truist Cuts Price Target on Integra LifeSciences Holdings to $12 From $13, Keeps Hold Rating |
| 2026-04-15 | -3.0% | legal | SEC EDGAR | IART 8-K: 1.01 (SEC Filing) |
| 2026-04-15 | -3.0% | earnings | Yahoo Finance | Q4 Rundown: Integra LifeSciences (NASDAQ:IART) Vs Other Surgical Equipment & Consumables - Specialty Stocks - Yahoo Finance |
| 2026-04-15 | -3.0% | news | Stock Titan | Integra LifeSciences (NASDAQ: IART) extends $150M receivables facility to 2029 - Stock Titan |
| 2026-04-15 | -3.0% | analyst | MSN | Argus Research downgrades Integra LifeSciences Holdings (IART) - MSN |
| 2025-10-18 | +3.0% | news | simplywall.st | Does Integra LifeSciences Share Rebound Signal a New Growth Phase in 2025? - simplywall.st |
| 2022-01-13 | +3.0% | legal | SEC EDGAR | IART 8-K: 8.01 (SEC Filing) |
| 2022-12-01 | +3.0% | legal | SEC EDGAR | IART 8-K: 7.01, 8.01 (SEC Filing) |
| 2021-12-15 | -2.9% | legal | SEC EDGAR | IART 8-K: 5.02 and (SEC Filing) |
| 2026-01-22 | -2.9% | news | AD HOC NEWS | Is Integra LifeSciences the Sneaky Healthcare Stock About To Explode or Just Background Noise? - AD HOC NEWS |
| 2025-12-12 | -2.9% | legal | SEC EDGAR | IART 8-K: 5.02 and (SEC Filing) |
| 2022-08-16 | -2.9% | analyst | TradingView | IART Forecast — Price Target — Prediction for 2027 - TradingView |
| 2026-01-29 | +2.9% | news | simplywall.st | Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)? - simplywall.st |
| 2025-04-22 | +2.9% | news | GlobeNewswire | Notice to Long-Term Shareholders of BioAge Labs, Inc. - GlobeNewswire |
| 2025-07-07 | -2.8% | news | Seeking Alpha | Integra LifeSciences: Struggling, Yet Getting Cheap |
| 2025-07-07 | -2.8% | news | Seeking Alpha | Integra LifeSciences: Struggling, Yet Getting Cheap (NASDAQ:IART) - Seeking Alpha |
| 2026-03-06 | -2.8% | news | StockStory | Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - StockStory |
| 2026-03-06 | -2.8% | news | TradingView | Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - TradingView |
| 2026-03-06 | -2.8% | news | The Globe and Mail | Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - The Globe and Mail |
| 2026-01-14 | +2.7% | news | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-02-09 | -2.7% | news | Investing.com | Integra LifeSciences stock faces scrutiny after Reuters report on TruDi system - Investing.com |
| 2025-12-03 | +2.7% | news | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Presents at Citi Annual Global Healthcare Conference 2025 Transcript |
| 2026-02-21 | -2.7% | analyst | The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Integra Lifesciences (IART) and Travere Therapeutics (TVTX) - The Globe and Mail |
| 2026-02-04 | +2.7% | news | Yahoo Finance | Investors in Integra LifeSciences Holdings (NASDAQ:IART) have unfortunately lost 84% over the last five years - Yahoo Finance |
| 2021-04-28 | -2.6% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2023-12-20 | +2.6% | legal | SEC EDGAR | IART 8-K: 1.01 (SEC Filing) |
| 2025-04-28 | +2.5% | news | GlobeNewswire | Notice to Long-Term Shareholders of Integra Lifesciences - GlobeNewswire |
| 2026-03-08 | -2.5% | earnings | StockStory | 3 Profitable Stocks with Open Questions - StockStory |
| 2026-04-11 | +2.5% | news | Simply Wall St. | Integra LifeSciences Holdings Insider Ups Holding By 28% During Year |
| 2025-06-09 | +2.4% | legal | SEC EDGAR | IART 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-03-11 | -2.3% | analyst | GuruFocus | Citigroup Maintains Sell Rating on IART and Lowers Price Target | IART Stock News - GuruFocus |
| 2021-06-24 | -2.2% | legal | SEC EDGAR | IART 8-K: 5.02 and (SEC Filing) |
| 2024-05-17 | -2.1% | legal | SEC EDGAR | IART 8-K: 8.01 (SEC Filing) |
| 2026-04-23 | -2.1% | news | Yahoo Finance | Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock - Yahoo Finance |
| 2026-02-25 | -2.0% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation Q4 2025 Earnings Preview |
| 2026-02-25 | -2.0% | earnings | TradingView | Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect - TradingView |
| 2026-02-25 | -2.0% | earnings | The Globe and Mail | Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect - The Globe and Mail |
| 2026-02-25 | -2.0% | earnings | Finviz | Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect - Finviz |
| 2024-09-19 | -2.0% | legal | Business Wire | Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm - Business Wire |
| 2026-04-17 | +1.9% | earnings | Zacks | Why Integra (IART) is Poised to Beat Earnings Estimates Again |
| 2026-04-17 | +1.9% | earnings | StockStory | Integra LifeSciences (IART): Buy, Sell, or Hold Post Q4 Earnings? |
| 2026-04-17 | +1.9% | earnings | StockStory | Integra LifeSciences (IART): Buy, Sell, or Hold Post Q4 Earnings? - StockStory |
| 2023-10-25 | -1.9% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | -1.8% | news | StockStory | Why Integra LifeSciences (IART) Shares Are Sliding Today - StockStory |
| 2026-03-12 | -1.8% | news | Yahoo Finance | Why Integra LifeSciences (IART) Shares Are Sliding Today - Yahoo Finance |
| 2026-03-12 | -1.8% | news | bitget.com | Why Integra LifeSciences (IART) Stock Is Falling Today - bitget.com |
| 2021-08-11 | +1.6% | earnings | Zacks Investment Research | What date does Integra LifeSciences's (IART) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2025-07-31 | +1.5% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.45 beats by $0.02, revenue of $415.6M beats by $20.54M |
| 2025-07-31 | +1.5% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2025-07-31 | +1.5% | earnings | MassDevice | Integra stock rises on Q2, continued FDA warning letter remediation - MassDevice |
| 2026-02-19 | +1.4% | news | The Globe and Mail | 1 Russell 2000 Stock to Target This Week and 2 That Underwhelm - The Globe and Mail |
| 2024-05-13 | +1.3% | legal | SEC EDGAR | IART 8-K: 5.02, 5.07, 8.01 (SEC Filing) |
| 2026-03-31 | +1.3% | earnings | MarketBeat | Integra LifeSciences Holdings Corporation $IART Position Decreased by JPMorgan Chase & Co. - MarketBeat |
| 2023-01-10 | -1.2% | legal | SEC EDGAR | IART 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-09-09 | +1.2% | news | GuruFocus | Davis Robert T. Jr. Net Worth (2026) - GuruFocus |
| 2023-09-20 | +1.2% | news | GlobeNewswire | INTEGRA LIFESCIENCES HOLDING CORPORATION (NASDAQ: IART) - GlobeNewswire |
| 2022-02-23 | +1.2% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2025-11-13 | -1.1% | news | Yahoo Finance | Integra LifeSciences (IART) Stock Trades Up, Here Is Why - Yahoo Finance |
| 2022-09-23 | +1.1% | legal | SEC EDGAR | IART 8-K: 5.02 and (SEC Filing) |
| 2025-09-22 | -1.1% | executive | Seeking Alpha | Integra LifeSciences appoints new Chief Medical Officer |
| 2026-03-24 | +1.1% | legal | Stock Titan | IART SEC Filings - Integra Lifesciences Hldgs Cp 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2025-11-11 | -1.0% | legal | Seeking Alpha | Integra gains FDA clearance to use CUSA Clarity Aspirator for cardiac surgeries |
| 2025-11-11 | -1.0% | legal | Investing.com | Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device - Investing.com |
| 2023-06-21 | -1.0% | legal | SEC EDGAR | IART 8-K: 5.02 and 7.01 (SEC Filing) |
| 2026-02-15 | +0.9% | news | AD HOC NEWS | The Truth About Integra LifeSciences: Wall Street Sleeper Or Next Big Healthtech Play? - AD HOC NEWS |
| 2025-03-20 | -0.9% | news | Intellectia AI | IART Forecast — Price Prediction for 2026. Should I Buy IART? - Intellectia AI |
| 2021-12-01 | -0.9% | legal | SEC EDGAR | IART 8-K: 5.02 (SEC Filing) |
| 2025-09-10 | -0.9% | news | Seeking Alpha | Integra LifeSciences Still Recovering From Self-Inflicted Wounds |
| 2025-09-10 | -0.9% | news | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2025-09-10 | -0.9% | news | Seeking Alpha | Integra LifeSciences Still Recovering From Self-Inflicted Wounds (NASDAQ:IART) - Seeking Alpha |
| 2024-07-14 | -0.8% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-05-11 | +0.8% | earnings | MarketBeat | Integra LifeSciences (IART) Stock Forecast and Price Target 2026 $IART - MarketBeat |
| 2025-04-25 | -0.8% | news | GlobeNewswire | Notice to Long-Term Shareholders of Integra Lifesciences - GlobeNewswire |
| 2023-01-25 | -0.8% | legal | SEC EDGAR | IART 8-K: 2.02 (SEC Filing) |
| 2023-01-25 | -0.8% | legal | SEC EDGAR | IART 8-K: 5.02 (SEC Filing) |
| 2026-02-26 | -0.8% | earnings | Seeking Alpha | Integra outlines $1.66B-$1.7B 2026 revenue target as new operating model drives transformation |
| 2026-02-26 | -0.8% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Q4 2025 Earnings Call Transcript |
| 2026-02-26 | -0.8% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-26 | -0.8% | earnings | Seeking Alpha | Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.83 beats by $0.03, revenue of $434.9M beats by $5.28M |
| 2026-02-26 | -0.8% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | -0.8% | news | Yahoo Finance | Integra LifeSciences (IART) Stock Trades Down, Here Is Why - Yahoo Finance |
| 2026-02-26 | -0.8% | earnings | Yahoo Finance | Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance |
| 2026-02-26 | -0.8% | earnings | Quiver Quantitative | INTEGRA LIFESCIENCES HLDGS ($IART) Releases Q4 2025 Earnings - Quiver Quantitative |
| 2026-02-26 | -0.8% | earnings | StockStory | Integra LifeSciences (NASDAQ:IART) Surprises With Q4 CY2025 Sales - StockStory |
| 2026-02-26 | -0.8% | earnings | Yahoo Finance | Integra (IART) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance |
| 2026-02-26 | -0.8% | earnings | Investing.com | Earnings call transcript: Integra LifeSciences beats Q4 2025 EPS forecast - Investing.com |
| 2026-02-26 | -0.8% | earnings | ChartMill | Integra LifeSciences (NASDAQ:IART) Beats Q4 2025 Earnings Estimates, Provides 2026 Outlook - ChartMill |
| 2022-12-14 | -0.8% | legal | SEC EDGAR | IART 8-K: 5.02 and (SEC Filing) |
| 2023-01-27 | +0.7% | legal | SEC EDGAR | IART 8-K: 8.01 (SEC Filing) |
| 2026-03-27 | -0.7% | news | Stock Titan | Vanguard disaggregates holdings; reports zero ownership in Integra (IART) - Stock Titan |
| 2026-04-07 | +0.7% | news | GlobeNewswire | Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization |
| 2026-04-07 | +0.7% | news | Stock Titan | 985 wound-care cases: Integra takes PriMatrix data to 3 conferences - Stock Titan |
| 2021-05-18 | +0.7% | legal | SEC EDGAR | IART 8-K: 5.02, 5.07 (SEC Filing) |
| 2023-03-24 | +0.7% | legal | SEC EDGAR | IART 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-07-19 | -0.6% | legal | SEC EDGAR | IART 8-K: 5.02 and (SEC Filing) |
| 2021-11-30 | -0.6% | analyst | eToro | IART Stock Price | Analyst Target 12.00 & Consensus - eToro |
| 2025-11-27 | -0.5% | news | simplywall.st | Why Integra LifeSciences Holdings (IART) Is Up 17.7% After Medicare Expands Reimbursement for Skin Substitutes - simplywall.st |
| 2026-03-29 | -0.5% | legal | Stock Titan | IART SEC Filings - Integra Lifesciences Hldgs Cp 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2021-07-28 | -0.5% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2023-08-16 | +0.5% | legal | SEC EDGAR | IART 8-K: 8.01 (SEC Filing) |
| 2026-04-16 | -0.5% | news | UBND thành phố Hải Phòng | Integra (IART) Stock Relative Weakness (Institutional Selling) 2026-04-16 - Stock Screening - UBND thành phố Hải Phòng |
| 2023-07-27 | -0.4% | legal | SEC EDGAR | IART 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-04-18 | +0.4% | news | Stock Traders Daily | How Integra Lifesciences Holdings Corporation (IART) Affects Rotational Strategy Timing - Stock Traders Daily |
| 2022-01-11 | +0.3% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2023-09-25 | -0.3% | news | GlobeNewswire | INTEGRA LIFESCIENCES HOLDING CORPORATION (NASDAQ: IART) - GlobeNewswire |
| 2022-08-29 | -0.2% | legal | SEC EDGAR | IART 8-K: 5.02 (SEC Filing) |
| 2026-03-26 | -0.2% | news | The Globe and Mail | 1 Small-Cap Stock Worth Your Attention and 2 We Turn Down - The Globe and Mail |
| 2023-02-22 | -0.2% | legal | SEC EDGAR | IART 8-K: 2.02 and (SEC Filing) |
| 2026-01-21 | -0.2% | news | Seeking Alpha | Integra LifeSciences Holdings Corporation (IART) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2025-06-16 | -0.2% | news | simplywall.st | Integra LifeSciences Holdings (NASDAQ:IART shareholders incur further losses as stock declines 12% this week, taking three-year losses to 78% - simplywall.st |
| 2025-12-24 | -0.1% | analyst | The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Integra Lifesciences (IART) - The Globe and Mail |
| 2022-04-27 | +0.1% | legal | SEC EDGAR | IART 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-04-24 | — | news | MSN | Here's why Integra LifeSciences (IART) is a strong momentum stock - MSN |